Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907987679> ?p ?o ?g. }
- W2907987679 abstract "Abstract Cellular microRNAs (miRNA) have proven to be critical regulators of inflammatory gene expression across many pathways within autoimmunity. Circulating miRNAs serve as a new class of disease biomarkers. Nevertheless, the functional roles of miRNAs, particularly extracellular miRNAs, in systemic lupus erythematosus (SLE) remain poorly understood. Therefore, we aimed to link changes in extracellular miRNAs to lymphocyte gene regulation and the pathophysiology of SLE. Here, we demonstrate that circulating miR-22-3p levels are associated with SLE, and miR-22-3p regulates T and B cell function and SLE-associated kidney disease. Based on high-throughput small RNA sequencing and real-time PCR, extracellular miR-22-3p levels were found to be significantly increased in whole plasma in human SLE subjects. To determine the functional impact of miR-22-3p in SLE, miR-22-3p loss-of-function studies were performed in a mouse model of SLE (B6. SLE1.2.3) . We found that in vivo administration of locked-nucleic acid inhibitors of miR-22-3p (LNA-22) reduced lymphocyte accumulation in both the spleen and lymph nodes compared to LNA scramble (LNA-Scr) control-treated mice. Strikingly, LNA-22-3p treatments reduced kidney disease pathology and glomerular IgG deposition compared to LNA-Scr treatments in SLE mice. Moreover, miR-22-3p inhibition reduced the proportion of T effector memory IFN-γ producing CD4 + T cells, suggesting that miR-22-3p regulates Th1 T cell differentiation. We also found that miR-22 inhibition in mice reduced STAT1 phosphorylation in the kidney which was correlated with loss of IFN-γ production by splenic CD4 + T cells. In conclusion, our findings suggest that miR-22-3p is a critical regulator of SLE-associated CD4 + T cell immunity and kidney disease. These results provide therapeutic potential for limiting splenic Th1 signaling and preventing the progression of lupus nephritis. Key Findings Extracellular miR-22-3p levels are significantly increased in plasma from human SLE subjects. Inhibition of miR-22-3p in vivo significantly reduced lymphocyte accumulation in both the spleen and lymph nodes in a mouse model of SLE, thus reducing splenomegaly and lymphadenopathy. miR-22-3p inhibition significantly reduced IFN-γ expression and secretion from splenic T cell subsets. Inhibition of miR-22-3p in vivo resulted in decreased IgG deposition in the kidney, decreased STAT1 phosphorylation, and decreased kidney disease in a mouse model of SLE." @default.
- W2907987679 created "2019-01-11" @default.
- W2907987679 creator A5000243126 @default.
- W2907987679 creator A5002615590 @default.
- W2907987679 creator A5004806142 @default.
- W2907987679 creator A5015550209 @default.
- W2907987679 creator A5027832987 @default.
- W2907987679 creator A5034964371 @default.
- W2907987679 creator A5036082483 @default.
- W2907987679 creator A5045122044 @default.
- W2907987679 creator A5063746086 @default.
- W2907987679 creator A5084933069 @default.
- W2907987679 creator A5087289405 @default.
- W2907987679 date "2019-01-07" @default.
- W2907987679 modified "2023-09-27" @default.
- W2907987679 title "Inhibition of miR-22-3p reduces kidney disease associated with systemic lupus erythematosus" @default.
- W2907987679 cites W144423133 @default.
- W2907987679 cites W1574385971 @default.
- W2907987679 cites W1888620010 @default.
- W2907987679 cites W1967261754 @default.
- W2907987679 cites W1972656711 @default.
- W2907987679 cites W1979024279 @default.
- W2907987679 cites W1992015602 @default.
- W2907987679 cites W2008462446 @default.
- W2907987679 cites W2015878901 @default.
- W2907987679 cites W2036534625 @default.
- W2907987679 cites W2041665769 @default.
- W2907987679 cites W2045300066 @default.
- W2907987679 cites W2051516968 @default.
- W2907987679 cites W2054004405 @default.
- W2907987679 cites W2058071683 @default.
- W2907987679 cites W2064999867 @default.
- W2907987679 cites W2074641102 @default.
- W2907987679 cites W2074995759 @default.
- W2907987679 cites W2078703666 @default.
- W2907987679 cites W2083865586 @default.
- W2907987679 cites W2090831287 @default.
- W2907987679 cites W2107871522 @default.
- W2907987679 cites W2108905161 @default.
- W2907987679 cites W2119650820 @default.
- W2907987679 cites W2127132484 @default.
- W2907987679 cites W2133402546 @default.
- W2907987679 cites W2136854370 @default.
- W2907987679 cites W2138207763 @default.
- W2907987679 cites W2141924564 @default.
- W2907987679 cites W2150535059 @default.
- W2907987679 cites W2152891840 @default.
- W2907987679 cites W2160692283 @default.
- W2907987679 cites W2162674813 @default.
- W2907987679 cites W2163535714 @default.
- W2907987679 cites W2166332777 @default.
- W2907987679 cites W2169456326 @default.
- W2907987679 cites W2179438025 @default.
- W2907987679 cites W2226246042 @default.
- W2907987679 cites W2425516388 @default.
- W2907987679 cites W2520298704 @default.
- W2907987679 cites W2557964709 @default.
- W2907987679 cites W2576120140 @default.
- W2907987679 cites W2740568036 @default.
- W2907987679 cites W2785810672 @default.
- W2907987679 cites W2789313896 @default.
- W2907987679 cites W2802099576 @default.
- W2907987679 cites W2952595797 @default.
- W2907987679 cites W3150252211 @default.
- W2907987679 doi "https://doi.org/10.1101/512848" @default.
- W2907987679 hasPublicationYear "2019" @default.
- W2907987679 type Work @default.
- W2907987679 sameAs 2907987679 @default.
- W2907987679 citedByCount "0" @default.
- W2907987679 crossrefType "posted-content" @default.
- W2907987679 hasAuthorship W2907987679A5000243126 @default.
- W2907987679 hasAuthorship W2907987679A5002615590 @default.
- W2907987679 hasAuthorship W2907987679A5004806142 @default.
- W2907987679 hasAuthorship W2907987679A5015550209 @default.
- W2907987679 hasAuthorship W2907987679A5027832987 @default.
- W2907987679 hasAuthorship W2907987679A5034964371 @default.
- W2907987679 hasAuthorship W2907987679A5036082483 @default.
- W2907987679 hasAuthorship W2907987679A5045122044 @default.
- W2907987679 hasAuthorship W2907987679A5063746086 @default.
- W2907987679 hasAuthorship W2907987679A5084933069 @default.
- W2907987679 hasAuthorship W2907987679A5087289405 @default.
- W2907987679 hasBestOaLocation W29079876791 @default.
- W2907987679 hasConcept C104317684 @default.
- W2907987679 hasConcept C126322002 @default.
- W2907987679 hasConcept C134018914 @default.
- W2907987679 hasConcept C145059251 @default.
- W2907987679 hasConcept C203014093 @default.
- W2907987679 hasConcept C2776912625 @default.
- W2907987679 hasConcept C2779134260 @default.
- W2907987679 hasConcept C2779912601 @default.
- W2907987679 hasConcept C2780091579 @default.
- W2907987679 hasConcept C2780130043 @default.
- W2907987679 hasConcept C2780931953 @default.
- W2907987679 hasConcept C28406088 @default.
- W2907987679 hasConcept C502942594 @default.
- W2907987679 hasConcept C55493867 @default.
- W2907987679 hasConcept C71924100 @default.
- W2907987679 hasConcept C86803240 @default.
- W2907987679 hasConcept C8891405 @default.
- W2907987679 hasConcept C95444343 @default.